Menu Search
Equities

Cooper Companies Inc

0I3I:LSE

Cooper Companies Inc

Actions
  • Price (USD)99.60
  • Today's Change1.16 / 1.18%
  • Shares traded563.00
  • 1 Year change+17.80%
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024 18:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.

  • Revenue in USD (TTM)3.80bn
  • Net income in USD359.30m
  • Incorporated1980
  • Employees15.00k
  • Location
    Cooper Companies Inc6101 Bollinger Canyon Road, Suite 500SAN RAMON 94583United StatesUSA
  • Phone+1 (925) 460-3600
  • Fax+1 (510) 460-3649
  • Websitehttps://www.coopercos.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.